| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:c-Fms-IN-10;c Fms IN 10,cFmsIN10
CAS:1527517-50-5
Purity:98% Package:100 mg;25 mg;50 mg
|
|
| | c-Fms-IN-10 Basic information |
| Product Name: | c-Fms-IN-10 | | Synonyms: | C-FMS-IN-10;c Fms IN 10,cFmsIN10;Thieno[3,2-d]pyrimidine-7-carboxamide, 4-amino-N-[3-methyl-1-[(6-methyl-2-pyridinyl)methyl]-1H-indazol-4-yl]- | | CAS: | 1527517-50-5 | | MF: | C22H19N7OS | | MW: | 429.5 | | EINECS: | | | Product Categories: | | | Mol File: | 1527517-50-5.mol |  |
| | c-Fms-IN-10 Chemical Properties |
| Boiling point | 632.5±55.0 °C(Predicted) | | density | 1.50±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 10.99±0.43(Predicted) |
| | c-Fms-IN-10 Usage And Synthesis |
| Description | c-Fms-IN-10 is the derivative of thieno [3,2-d] pyrimidine, an kinase inhibitor of FMS (Colony stimulating factor-1 receptor, CSF-1R) with IC50 of 2 nM.c-Fms-IN-10 has anti-tumor activity[1].
| | References | [1]. Kim YY, et al. Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors. Bioorg Med Chem Lett. 2019 Jan 15;29(2):271-275. |
| | c-Fms-IN-10 Preparation Products And Raw materials |
|